Dinesh K. Kalra

Dr. Dinesh K. Kalra

University of Louisville, Louisville, Colorado, USA
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2013 in Journal of Internal Medicine
Verified
Journal Article
Closed access
PDF file
PCP. Coorevits
P. Coorevits
MSM. Sundgren
M. Sundgren
GKG. O. Klein
G. O. Klein
ABA. Bahr
A. Bahr
BCB. Claerhout
B. Claerhout
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra

10 April 2021 in Informatics for Health and Social Care
Verified
Journal Article
Open access
ATArchana Tapuria
Archana Tapuria
TPTalya Porat
Talya Porat
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
GDGlen Dsouza
Glen Dsouza
SXSun Xiaohui
Sun Xiaohui
VCVasa Curcin
Vasa Curcin
Patient access to their own electronic health records (EHRs) is likely to become an integral part of healthcare systems worldwide. It has the potential to decrease the healthcare provision costs, improve access to healthcare data, self-care, quality of care, and health and patient-centered outcomes. This systematic literature review is aimed at identifying the impact in terms of benefits and issues that have so far been demonstrated by providing patients access to their own EHRs, via providers’ secure patient portals from primary healthcare centers and hospitals. Searches were conducted in PubMed, MEDLINE, CINHAL, and Google scholar. Over 2000 papers were screened and were filtered based on duplicates, then by reading the titles and finally based on their abstracts or full text. In total, 74 papers were retained, analyzed, and summarized. Papers were included if providing patient access to their own EHRs was the primary intervention used in the study and its impact or outcome was evaluated. The search technique used to identify relevant literature for this paper involved input from five experts. While findings from 54 of the 74 papers showed positive outcome or benefits of patient access to their EHRs via patient portals, 10 papers have highlighted concerns, 8 papers have highlighted both and 2 have highlighted absence of negative outcomes. The benefits range from re-assurance, reduced anxiety, positive impact on consultations, better doctor–patient relationship, increased awareness and adherence to medication, and improved patient outcomes (e.g., improving blood pressure and glycemic control in a range of study populations). In addition, patient access to their health information was found to improve self-reported levels of engagement or activation related to self-management, enhanced knowledge, and improve recovery scores, and organizational efficiencies in a tertiary level mental health care facility. However, three studies did not find any statistically significant effect of patient portals on health outcomes. The main concerns have been around security, privacy and confidentiality of the health records, and the anxiety it may cause amongst patients. This literature review identified some benefits, concerns, and attitudes demonstrated by providing patients’ access to their own EHRs. This access is often part of government strategies when developing patient-centric self-management elements of a sustainable healthcare system. The findings of this review will give healthcare providers a framework to analyze the benefits offered by promoting patient access to EHRs and decide on the best approach for their own specialties and clinical setup. A robust cost-benefit evaluation of such initiatives along with its impact on major stakeholders within the healthcare system would be essential in understanding the overall impact of such initiatives. Implementation of patient access to their EHRs could help governments to appropriately prioritize the development or adoption of national standards, whilst taking care of local variations and fulfilling the healthcare needs of the population, e.g., UK Government is aiming to make full primary care records available online to every patient. Ultimately, increasing transparency and promoting personal responsibility are key elements of a sustainable healthcare system for future generations.

7 May 2002 in Circulation
Verified
Journal Article
Closed access
PDF file
GBGeorg Baumgarten
Georg Baumgarten
PKPascal Knuefermann
Pascal Knuefermann
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
FGFeng Gao
Feng Gao
GTGeorge E. Taffet
George E. Taffet
DMDouglas L Mann
Douglas L Mann
Background — Although previous studies have examined the effects of acute hemodynamic pressure overload on proinflammatory cytokine gene expression, the effects of sustained hemodynamic overloading have not been examined. Methods and Results — Sustained hemodynamic pressure overloading was produced in mice by transverse constriction of the aorta. Proinflammatory cytokine and cytokine receptor gene expression were determined by ribonuclease protection assays (RPA) at 6 hours and at 3, 7, 14 and 35 days after banding. M-mode echocardiography was used to assess left ventricular structure and function at identical time points. RPA showed that tumor necrosis factor (TNF), interleukin (IL)-1β, and IL-6 mRNA levels were maximal at 6 hours and returned to baseline levels within 72 hours. There was a significant increase in IL-1RII and IL-6Rα receptor mRNA levels after overloading but no significant increase in TNFR1, TNFR2, IL-1RI, or gp130 mRNA levels. The transient increase in expression of proinflammatory cytokine gene expression was not explained by changes in left ventricular loading conditions, left ventricular wall stress, desensitization of proinflammatory genes, or decreased nuclear factor-κB activation. It is interesting that transverse constriction of the aorta provoked an increase in the expression of tristetraprolin, a homeostatic zinc finger protein that is known to destabilize TNF mRNA. Conclusion — Sustained hemodynamic overloading provokes a transient increase in proinflammatory cytokine and cytokine receptor gene expression; however, the decrease in proinflammatory cytokine gene expression occurred in the absence of changes in loading conditions, suggesting that the expression of proinflammatory cytokines in the heart is regulated, at least in part, by load-dependent and load-independent mechanisms.

7 May 2002 in Circulation
Verified
Journal Article
Closed access
PDF file
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
NSNatarajan Sivasubramanian
Natarajan Sivasubramanian
DMDouglas L Mann
Douglas L Mann
Background — Previous studies suggest that angiotensin II (Ang II) upregulates the expression of tumor necrosis factor (TNF) in nonmyocyte cell types; however, the effect of Ang II on TNF expression in the adult mammalian heart is not known. Methods and Results — To determine whether Ang II was sufficient to provoke TNF biosynthesis in the adult heart, we examined the effects of Ang II in isolated buffer-perfused Langendorff feline hearts. Ang II (10 −7 mol/L) treatment resulted in a time- and dose-dependent increase in myocardial TNF mRNA and protein biosynthesis in the heart as well as in cultured adult cardiac myocytes. The effects of Ang II on myocardial TNF mRNA and protein synthesis were mediated through the angiotensin type 1 receptor (AT 1 R), insofar as an AT 1 R antagonist (AT 1 a) blocked the effects of Ang II, whereas an angiotensin type 2 receptor (AT 2 R) antagonist (AT 2 a) had no effect. Stimulation with Ang II led to the activation of nuclear factor-κB and activator protein-1 (AP-1), two transcription factors that are important for TNF gene expression. Nuclear factor-κB activation was accompanied by phosphorylation of IκBα on serine 32 as well as degradation of IκBα, suggesting that the effects of Ang II were mediated through an IκBα-dependent pathway. The important role of protein kinase C (PKC) was suggested by studies in which a phorbol ester triggered TNF biosynthesis, and a PKC inhibitor abrogated Ang II–induced TNF biosynthesis. Conclusions — These studies suggest that Ang II provokes TNF biosynthesis in the adult mammalian heart through a PKC-dependent pathway.

28 December 2023 in JACC: Advances
Verified
Journal Article
Open access
USUsman Sagheer
Usman Sagheer
SASadeer Al-Kindi
Sadeer Al-Kindi
SAShady Abohashem
Shady Abohashem
CPColin T. Phillips
Colin T. Phillips
JRJamal S. Rana
Jamal S. Rana
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Over the past 50 years, there has been a substantial decline in the incidence of CVD and related mortality in high-income countries, largely due to the mitigation of modifiable risk factors such as smoking, hypertension, and diabetes. However, a significant burden of CVD remains in low- to middle-income countries, despite their lower prevalence of traditional risk factors; other environmental factors, particularly pollution, play a significant role in this attributable risk. Mounting evidence underscores a strong association between pollution and adverse health effects, including CVD. This article is part 1 of a 2-part state-of-the-art review and discusses air pollution and its adverse effects on CVD, highlighting pathophysiological mechanisms and methods to reduce air pollution and exposure to these pollutants.

1 November 1998 in Cardiology Clinics
Verified
Journal Article
Closed access
SKSamir Kapadia
Samir Kapadia
ZDZiad Dibbs
Ziad Dibbs
KKKarla Kurrelmeyer
Karla Kurrelmeyer
Dinesh K. KalraDinesh K. Kalra
Dinesh K. Kalra
YSYukihiro Seta
Yukihiro Seta
DMDouglas L Mann
Douglas L Mann